BioWorld

May 10, 2002

Bush's Zerhouni Confirmed By Senate As NIH Director

WASHINGTON - President Bush's choice as director of the National Institutes of Health won Senate confirmation, just in time to enter the pending debate on Capitol Hill concerning therapeutic cloning. (BioWorld Today) Read More

Onyx Placement Gets $20M To Pursue Anticancer Drugs

Merck Scientists' Compound Pinpoints B. anthracis Lethal Toxin As Antibiotics Adjunct

Genome Canada Supporting National Genomics Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

Illustration of glucose in the blood stream

CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

BioWorld Science

Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...

Saniona reports preclinical data for SAN-2668

BioWorld Science

Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...

CC-3 antibody shows antitumoral activity in penile cancer

BioWorld Science

Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...